The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1829-1840

  Pahl, Heike L ^a   Krauß, Beate ^a   Schulze Osthof, Klaus ^a   Decker, Thomas ^b   Traenckner, E Britta Mareen ^a   Vogt, Markus ^a   Myers, Christina ^c   Parks, Tom ^c   Warring, Paul ^d   Mühlbacher, Arno ^d   Czernilofsky, Armin Peter ^e   Baeuerle, Patrick A ^a,f  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Vienna Biocenter   (Austria)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^d Biology and Environment   (Australia)

^e BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^f AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIOTOXIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; DNA BINDING; IMMUNOSUPPRESSIVE TREATMENT; MESENTERY LYMPH NODE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

CELLS, CULTURED; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENES, REPORTER; GLIOTOXIN; HUMANS; I-KAPPA B PROTEINS; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; NF-KAPPA B; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN-TYROSINE KINASES; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 15844381960     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1829     Document Type: Article

References (60)

1. Bodey, G.P. 1988. The emergence of fungi as major hospital pathogens. J. Hosp. Infect. 11:411-426.
2. Bodey, G., B. Bueltmann, W. Duguid, D. Gibbs, H. Hanak, M. Hotchi, G. Mall, P. Martmo, F. Meunier, S. Milhken et al. 1992. Fungal infections in cancer patients: an international autopsy survey. Eur. J. Clin. Microbiol. Infect. Dis. 11:99-109.
3. Waring, P., R.D. Eichner, and A. Müllbacher. 1988. The chemistry and biology of the immunomodulating agent gliotoxin and related epipolythiodioxopiperazines. Med. Res. Rev. 8:499-524.
4. Taylor, A. 1971. The toxicology of sporidesmis and other epipolythiodioxopiperaziries. Microb. Toxins. 7:337-376
5. Sutton, P., N.R. Newcombe, P. Waring, and A. Müllbacher. 1994. In vivo immunosuppressive activity of gliotoxin, a metabolitc produced by human pathogenic fungi. Infect. and Immun. 62:1192-1198.
6. Müllbacher, A., and R.D. Eichner. 1984. Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc. Natl. Acad. Sci. USA. 81:3835-3837.
7. 2+ salts. Int. J. Immunopharmacol. 12:445-457.
8. Waring, P., E.R. D., A. Müllbacher, and A. Sjaarda. 1988. Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J. Biol. Chem. 263:18493-18499.
9. Braithwaite, A.W., R.D. Eichner, P. Waring, and A. Müllbacher. 1987. The immunomodulating agent gliotoxin causes genomic DNA fragmentation. Mol Immunol. 24:47-55.
10. Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179.
11. Bacuerle, P.A., and D. Baltimore. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappaB transcription factor. Cell. 53:211-217.
12. Henkel, T., T. Machleidt, I. Alkalay, Y. Ben-Neriah, M. Krönke, and P.A. Bacuerle. 1993. Rapid proteolytic degradation of IκB-α induced by stimulation of cells with phorbol ester, cytokines and liposaccharides is a necessary step in the activation of NF-κB. Nature (Lond.). 365:182-184.
13. Beg, A.A., T.S. Finco, P.V. Nantermet, and A.S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukm-1 lead to phosphorylation and loss of IκB-α: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301-3310.
14. Traenckner, E.B.-M., S. Wilk, and P.A. Baeuerle. 1994. A protcasomc inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO (Eur. Mol Biol Organ.) J. 13:5433-5441.
15. Sun, S.-C., P.A. Ganchi, C. Béraud, D.W. Ballard, and W.C. Greene. 1994. Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl. Acad. Sci. USA. 87:1346-1350.
16. Traenckner, E.B.-M., H.L. Pahl, T. Henkel, K.N. Schmidt, S. Wilk, and P.A. Baeuerle. 1995. Phosphorylation of human IκB-α on serine 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO (Eur. Mol Biol. Organ.) J. 14:2876-2883.
17. Grimm, S., and P.A. Baeuerle. 1993. The mducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem. J. 290:297-308.
18. Sha, W.C., H.-C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune reponses. Cell. 80:321-330.
19. Beg, A.A., W.C. Sha, R.T. Bronson, S. Gosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature (Lond.). 376:167-170.
20. Köntgen, F., R.J, Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogenc exhibit defects in lymphocyte proliferation, humoral immunity and interleukin-2 expression. Genes & Dev. 9:1965-1977.
21. Rao, A. 1994. NFATp, a transcription factor required for the coordinate induction of several lymphokine genes. Immunol. Today. 15:274-281.
22. Rao, A. 1995. NFATp, a cyclosporin-sensitive transcription factor implicated in cytokine gene instruction. J. Leukocyte Biol. 57:536-542.
23. Crabtree, G.R., and N.A. Clipstone. 1994. Signal transduction between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 63:1045-1083.
24. Liu, J., J.D. Farmer Jr., W.S. Lane, J. Friedman, I. Weissman, and S.L. Schreiber. 1991. Calcineurin is a common target of cyclophillin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:807-815.
25. McCaffrey, P.G., C. Luo, T.K. Kerppola, J. Jain, T.M. Badalian, A.M. Ho, E. Burgeon, W.S. Lane, J.L. Lambert, T. Curran et al. 1993. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science (Wash. DC). 262: 750-754.
26. Hall, B.M. 1982. Immunosuppression in renal transplantation. Med. J. Austr. 2:415-418.
27. White, D.J. 1982. Concanavilin: clinical pharmacology and therapeutic potential. Drugs. 24:322-334.
28. Bowman, H., and T.W. Lennard. 1992. Immunosuppressive drugs (review). Br. J. Hosp. Med. 48:570-573.
29. Levy, D.E., D.S. Kessler, R. Pine, and J.E. Darnell, Jr. 1989. Cytoplasmic activation of ISGF-3, the positive regulator of interferon-α-stimulated transcription, reconstituted in vitro. Genes. Dev. 3:1362-1371.
30. Darnell, J.F., Jr., I.M. Kerr, and G.R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins. Science (Wash. DC). 264:1415-1421.
31. Sadowski, H.B., K. Shuai, J.E. Darnell, Jr., and M.Z. Gilman. 1993. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science (Wash. DC). 261:1739-1744.
32. Silvennomen, O., C. Schindler, J. Schlessinger, and D.E. Levy. 1993. Ras-mdependent growth factor signalling by transcription factor tyrosine phosphorylation. Science (Wash. DC). 261:1736-1739.
33. Ruff-Jamison, S., K. Chen, and S. Cohen. 1995. Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat 5 in mouse liver. Proc. Natl. Acad. Sci. USA. 92:4215-4218.
34. Bacon, C.M., E.F. Petricoin III, J.R. Ortaldo, R.C. Rees, A.C. Lamer, J.A. Johnston, and J.J. O'Shea. 1995. IL-12 induces tyrosine phosphorylation and activation of Stat 4 in human lymphocytes. Proc. Natl. Acad. Sci. USA. 92:7303-7311.
35. Kotanides, H., M. Moczygemba, M.F. White, and N.C. Reich. 1995. Characterization of the interleukin-4 nuclear activated factor/STAT and its activation independent of the insulin receptor substrate proteins. J. biol. Chem. 270:19481-19486.
36. Frank, D.A., M.J. Robertson, A. Bonni, J. Ritz, and M.E. Greenberg. 1995. Interleukin-2 signalling involves the phosphorylation of Stat proteins. Proc. Natl. Acad. Sci. USA. 92: 7779-7783.
37. Ledebur H.C., and T.P. Parks. 1995. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J. Biol. Chem. 270:933-943.
38. Hou, J., V. Baichwal, and Z. Cao. 1994. Regulatory elements and transcription factors controlling basal and cytokme-induced expression of the gene encoding intercellular adhesion molecule 1. Proc. Natl Acad. Sci USA. 91:11641-11645.
39. van de Stolpe, A., E. Caldenhoven, B.C. Stade, L. Koenderman, J.A.M. Raaijmakers, J-P. Johnson, and P.T. van der Saag. 1994. 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor-α mediated induction of intercellular adhsion molecule-1 is inhibited by dexamethasone. J. Biol. Chem. 269:6185-6192.
40. Kieran, M., V. Blank, F. Logeat, J. Vandekerckhove, F. Lottspeich, O. Le Bail, M.R. Urban, P. Kounlsky, P.A. Baeucrle, and A. Israel. 1990. The DNA binding subunit of NF-kappa B is identical to factor KBF-1 and homologous to the rel oncogene product. Cell. 62:1007-1018.
41. Li-Weber, M., H. Krafft, and P.H. Krammer. 1993. A novel enhancer element in the human IL-4 promoter is suppressed by a position-independent silencer. J. Immunol. 151:1371-1382.
42. Reich, N.C., B. Evans, D.E. Levy, D.E. Fahey, E. Knight, and J.E. Darnell. 1987. Interferon-induced transcription of a gene encoding a 15 kDa protein depends on an upstream enhancer element. Proc. Natl. Acad. Sci. USA. 84:6394-6398.
43. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor IκB-α. Proc. Natl. Acad. Sci. USA. 90:2532-2536.
44. Safe, S., and A. Taylor. 1970. Spondesmins. X. Synthesis of polysulfides by reaction of dihydrogen disulfide with disufides and thiols. J. Chem. Soc. 3:432-435.
45. Müllbacher, A., P. Waring, U. Tiwari-Palni, and R. Eichner. 1986. Structural relationship of epipolythiodioxopiperazines and their immunomodulating activity. Mol. Immunol. 23: 231-235.
46. Levy, D.E., D.J. Lew, T. Decker, D.S. Kessler, and J.E. Darnell, Jr. 1990. Synergistic interaction between interferon-α and Interferon-γ through induced synthesis of one subunit of the transcription factor ISGF3. EMBO (Eur. Mol Biol. Organ.) J. 9:1105-1111.
47. Pine, R., A. Canova, and C. Schindler. 1994. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFN-γ, and is likely to autoregulate the p91 gene. EMBO (Eur. Mol. Biol. Organ.) J. 13:158-167.
48. Wiegmann, K., S. Schütze, E. Kampen, A Himmler, T. Machleidt, and M. Kröncke. 1992. Human 55 kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J. Biol Chem. 267:17997-18001.
49. Matthews, J R., N. Wakasugi, J.-L. Virelizier, J. Yodoi, and R.T. Hay. 1992. Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond invoving cysteine 62. Nucleic Acids Res. 30:3821-3830.
50. Kumar, S., A.B. Rabson, and C. Gelinas. 1992. The Rxx-RxRxxC motif conserved in all Rel/κB proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein. Mol. Cell. Biol. 12:3094-3106.
51. Toledano, M.B., and W.J. Leonhard. 1991. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA. 88:4328-4332.
52. Eichner, R.D., P. Waring, A.M. Geue, A.W. Braithwaite, and A. Müllbacher. 1988. Gliotoxin causes oxidative damage to plasmid and cellular DNA. J. Biol. Chem. 263:3772-3777.
53. Urban, M.B., and P.A. Baeuerle. 1991. The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences. New Biol. 3:279-288.
54. Chaw, A.C., D.M. Desai, and A. Weiss. 1994. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12:555-592.
55. Howe, L.R., and A. Weiss. 1995. Multiple kinases mediate T-cell-receptor signalling. TIBS (Trends Biochem. Sci.) 20: 59-64.
56. Burch, P.A., J.E. Karp, W.G. Merz, J.E. Kuhlman, and E.K. Fishman. 1987. Favorable outcome of invasive aspergillosis in patients with acute leukemia. J. Clin. Oncol. 5:1985-1993.
57. 2+ release from intact rat liver mitochondria. Biochemistry. 33:13401-13405.
58. Beaver, J.P., and P. Waring. 1994. Lack of correlation between early intracellular calcium ion rises and the onset of apoptosis in thymocytes. Immunol. Cell Biol. 72:489-499.
59. Eichner, R D., M. al Salami, R.P. Wood, and A. Müllbacher. 1986. The effect of gliotoxin upon macrophage function. Int. J. Immunophannacol. 8:789-797.
60. Hoyos, B., D.W. Ballard, E. Böhnlem, M. Siekevitz, and W. C. Greene. 1989. Kappa B-specific DNA binding proteins: role in the regulation of human interleukm-2 gene expression. Science (Wash. DC) 244:457-460.